Most cited papers from Qurient (South Korea)

Qurient (South Korea)

What are the most cited papers from Qurient (South Korea)?

The most cited paper from Qurient (South Korea) is "Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis" (Kévin Pethe et al., 2013), with 621 citations. Next come "A Comparative Study of Modern Inference Techniques for Discrete Energy Minimization Problems" (202) and "Lead Optimization of a Novel Series of Imidazo[1,2-a]pyridine Amides Leading to a Clinical Candidate (Q203) as a Multi- and Extensively-Drug-Resistant Anti-tuberculosis Agent" (178).

Published TypeFieldAccessCitations

Showing 29 of 29 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis Kévin Pethe et al. · Nature Medicine Open access	4 Aug 2013	621
2	A Comparative Study of Modern Inference Techniques for Discrete Energy Minimization Problems Jörg Hendrik Kappes, Bjoern Andres, Fred A. Hamprecht et al. Conference paper	Jun 2013	202
3	Lead Optimization of a Novel Series of Imidazo[1,2-a]pyridine Amides Leading to a Clinical Candidate (Q203) as a Multi- and Extensively-Drug-Resistant Anti-tuberculosis Agent Sun‐Hee Kang et al. · Journal of Medicinal Chemistry Open access	28 May 2014	178
4	Telacebec (Q203), a New Antituberculosis Agent Veronique R. De Jager, Rodney Dawson, Christo van Niekerk et al. · New England Journal of Medicine Open access	25 Mar 2020	142
5	A locally funded Puerto Rican parrot (Amazona vittata) genome sequencing project increases avian data and advances young researcher education Tarás K. Oleksyk, Jean‐François Pombert, Daniel Siu et al. · GigaScience Open access	28 Sep 2012	51
6	Synthesis and structure-activity studies of side chain analogues of the anti-tubercular agent, Q203 Sun‐Hee Kang, Young Mi Kim, Ryang Yeo Kim et al. · European Journal of Medicinal Chemistry	30 Sep 2016	44
7	Safety, Tolerability, and Pharmacokinetics of Telacebec (Q203), a New Antituberculosis Agent, in Healthy Subjects Jeongjun Kim, Jin‐Ho Choi, Hwankyu Kang et al. · Antimicrobial Agents and Chemotherapy Open access	25 Oct 2021	39
8	Telacebec for Ultrashort Treatment of Buruli Ulcer in a Mouse Model Deepak V. Almeida, Paul J. Converse, Till Frederik Omansen et al. · Antimicrobial Agents and Chemotherapy Open access	20 Mar 2020	35
9	Synthesis and structure-activity relationships of novel fused ring analogues of Q203 as antitubercular agents Sun‐Hee Kang, Young Mi Kim, Hee-Kyung Jeon et al. · European Journal of Medicinal Chemistry	10 May 2017	28
10	Inhibition of AXL ameliorates pulmonary fibrosis via attenuation of M2 macrophage polarisation Dong Ha Kim, Ho Cheol Kim, Kyungtaek Im et al. · European Respiratory Journal Open access	9 Jan 2025	27
11	A Novel Selective Axl/Mer/CSF1R Kinase Inhibitor as a Cancer Immunotherapeutic Agent Targeting Both Immune and Tumor Cells in the Tumor Microenvironment Yeejin Jeon, Hwankyu Kang, Yeongin Yang et al. · Cancers Open access	2 Oct 2022	21
12	Telacebec, a Potent Agent in the Fight against Tuberculosis: Findings from a Randomized, Phase 2 Clinical Trial and Beyond Saskia Janssen, Caryn M. Upton, Veronique R. De Jager et al. · American Journal of Respiratory and Critical Care Medicine Open access	21 Mar 2025	17
13	Effective work function tunability and interfacial reactions with underlying HfO2 layer of plasma-enhanced atomic layer deposited TaCxNy films Tae Joo Park, Jeong Hwan Kim, Jae Hyuck Jang et al. · Applied Physics Letters	19 May 2008	17
14	Safety, Tolerability, Pharmacokinetics, and Metabolism of Telacebec (Q203) for the Treatment of Tuberculosis: a Randomized, Placebo-Controlled, Multiple Ascending Dose Phase 1B Trial Jeongjun Kim, Jin‐Ho Choi, Hwankyu Kang et al. · Antimicrobial Agents and Chemotherapy Open access	12 Dec 2022	16
15	An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity DongHoon Yu, Sabrina Wagner, Martin Schütz et al. · Pharmaceutics Open access	23 Jan 2024	14
16	Synthesis and Electrochemical Performance of π-Conjugated Molecule Bridged Silicon Quantum Dot Cluster as Anode Material for Lithium-Ion Batteries Young‐Hwa Choi, Hyeonbeom Park, Sunyoung Lee et al. · ACS Omega Open access	7 Apr 2020	13
17	28.1 A Capacitive Touch Chipset with 33.9dB Charge-Overflow Reduction Using Amplitude-Modulated Multi-Frequency Excitation and Wireless Power and Data Transfer to an Active Stylus Jae-Sung An, Jong-Hyun Ra, Eunchul Kang et al. Conference paper	Feb 2020	8
18	OmniStitch: Depth-Aware Stitching Framework for Omnidirectional Vision with Multiple Cameras S.G. Kim, Soyeon Hong, Gyung-Soo Park et al. Conference paperOpen access	26 Oct 2024	6
19	Demand Paging Techniques for Flash Memory Using Compiler Post-Pass Optimizations Seungkyun Kim, Kiwon Kwon, Chihun Kim et al. · ACM Transactions on Embedded Computing Systems	Nov 2011	5
20	The role of cytochrome bc1 inhibitors in future tuberculosis treatment regimens Clara Aguilar-Pérez et al. · Nature Communications Open access	22 Oct 2025	4
21	Novel modeling approach integrating population pharmacokinetics and interspecies scaling to predict human pharmacokinetics of the new anti-tuberculosis agent telacebec (Q203) Jeongjun Kim, Tae‐Hwan Kim, Jin‐Ho Choi et al. · Biomedicine & Pharmacotherapy Open access	9 Sep 2023	2
22	Influence of bridge structure manipulation on the electrochemical performance of π-conjugated molecule-bridged silicon quantum dot nanocomposite anode materials for lithium-ion batteries Young‐Hwa Choi, Jiyoung Bang, Sunyoung Lee et al. · Nanoscale Advances Open access	2023	2
23	712TiP A phase I/II multicenter, open-label, dose-escalation, safety, pharmacodynamic, and pharmacokinetic study of Q901 administered via intravenous infusion in adult patients with selected advanced solid tumors with a cohort expansion at the recommended phase II dose Angela Tatiana Alistar, Devalingam Mahalingam, Minal A. Barve et al. · Annals of Oncology Open access	Oct 2023	1
24	VISUALIZATION OF NUMERICALRESULTS OF MESHLESS METHOD AND ITS REALIZATION Mingwu Yuan · Engineering Mechanics	2004	1
25	Growth of Germanium Islands, Wires, or Films from CVD with a New Precursor Sang‐Woo Kang, Jintae Kim, Ju‐Young Yun et al. · Chemical Vapor Deposition	28 Aug 2009	1
26	Sensitizing tumor response to topoisomerase I antibody drug conjugate by selective CDK7 inhibition Hyerim Jung, Yoonji Lee, Donghoon Yu et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access	25 Nov 2025	0
27	Insights into the use of cytochrome bc1 inhibitors for future therapeutic strategies for tuberculosis Clara Aguilar Pérez et al. · Research Square PreprintOpen access	31 Oct 2024	0
28	The Inhibiting Effects of Extracts from the Ginkgo (Ginkgo biloba L.) Testas Against Pathogen Cylindrocladium colhounii Yu Luan · Zhiwu yanjiu	2007	0
29	Effects of Tongxingluo on Serum Soluble Cell Adhesion Molecules in Patients with Unstable Angina Pectoris Xing Li	2005	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.